Insights into Targeted and Stimulus‐Responsive Nanocarriers for Brain Cancer Treatment
Advanced Healthcare Materials · 2024-05 · 13 (12)
DOI: 10.1002/adhm.202302902 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, online erschienen am 07.03.2024. Verfasst von Zahra Abousalman-Rezvani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Melbourne, VIC 3052, Austr…. Hauptthemen laut MEDLINE: Brain Neoplasms, Drug Carriers, Nanoparticles. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 313 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Melbourne Centre for Nanofabrication, Australian National Fabrication Facility, Australian Research Council.
Abstract (Originalsprache)
Brain cancers, especially glioblastoma multiforme, are associated with poor prognosis due to the limited efficacy of current therapies. Nanomedicine has emerged as a versatile technology to treat various diseases, including cancers, and has played an indispensable role in combatting the COVID‐19 pandemic as evidenced by the role that lipid nanocarrier‐based vaccines have played. The tunability of nanocarrier physicochemical properties —including size, shape, surface chemistry, and drug release kinetics— has resulted in the development of a wide range of nanocarriers for brain cancer treatment. These nanocarriers can improve the pharmacokinetics of drugs, increase blood‐brain barrier transfer efficiency, and specifically target brain cancer cells. These unique features would potentially allow for more efficient treatment of brain cancer with fewer side effects and better therapeutic outcomes. This review provides an overview of brain cancers, current therapeutic options, and challenges to efficient brain cancer treatment. The latest advances in nanomedicine strategies are investigated with an emphasis on targeted and stimulus‐responsive nanocarriers and their potential for clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Melbourne, VIC 3052, Australia.
- Biomedical Manufacturing, Commonwealth Scientific and Industrial Research Organization, Research Way, Melbourne, VIC 3168, Australia.
- Pharmaceutics Department, Faculty of Pharmacy - Alexandria University, 1 El-Khartoum Square, Alexandria, 21021, Egypt.
- Faculty of Polymer Engineering, Sahand University of Technology, Tabriz, P.O. Box: 51335/1996, Iran.
- Melbourne Centre for Nanofabrication, Victorian Node of the Australian National Fabrication Facility, 151 Wellington Rd, Melbourne, VIC 3168, Australia.
- Department of Materials Science & Engineering, Faculty of Engineering, Monash University, 14 Alliance Ln, Melbourne, VIC 3168, Australia.
ORCID-Profile: Zahra Abousalman-Rezvani, Ahmed Refaat, Pouya Dehghankelishadi, Hossein Roghani-Mamaqani, Lars Esser, Nicolas H Voelcker
Förderung
- Melbourne Centre for Nanofabrication
- Australian National Fabrication Facility
- Australian Research Council
- Monash Graduate Scholarship
- CASS Foundation
- Tour de Cure
Zitieren
APA
Abousalman-Rezvani, Z., Refaat, A., Dehghankelishadi, P., Roghani-Mamaqani, H., Esser, L., & Voelcker, N. H. (2024). Insights into Targeted and Stimulus‐Responsive Nanocarriers for Brain Cancer Treatment. Advanced Healthcare Materials, 13(12). https://doi.org/10.1002/adhm.202302902
Vancouver
Abousalman-Rezvani Z, Refaat A, Dehghankelishadi P, Roghani-Mamaqani H, Esser L, Voelcker NH. Insights into Targeted and Stimulus‐Responsive Nanocarriers for Brain Cancer Treatment. Advanced Healthcare Materials. 2024;13(12). doi:10.1002/adhm.202302902
BibTeX
@article{AbousalmanRezvani2024,
author = {Abousalman-Rezvani, Zahra and Refaat, Ahmed and Dehghankelishadi, Pouya and Roghani-Mamaqani, Hossein and Esser, Lars and Voelcker, Nicolas H},
title = {Insights into Targeted and Stimulus‐Responsive Nanocarriers for Brain Cancer Treatment},
journal = {Advanced Healthcare Materials},
year = {2024},
volume = {13},
number = {12},
doi = {10.1002/adhm.202302902}
}
EUVIMED